Global Tissue Diagnostics Industry

ReportLinker
·25-min read

Global Tissue Diagnostics Market to Reach US$5. 3 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Tissue Diagnostics estimated at US$3. 8 Billion in the year 2020, is projected to reach a revised size of US$5.

New York, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Diagnostics Industry" - https://www.reportlinker.com/p05799811/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 4.9% over the period 2020-2027.Consumables, one of the segments analyzed in the report, is projected to grow at a 5.5% CAGR to reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 3.8% CAGR for the next 7-year period. This segment currently accounts for a 32.8% share of the global Tissue Diagnostics market.

The U.S. Accounts for Over 27.2% of Global Market Size in 2020, While China is Forecast to Grow at a 8.4% CAGR for the Period of 2020-2027

The Tissue Diagnostics market in the U.S. is estimated at US$1 Billion in the year 2020. The country currently accounts for a 27.24% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1.1 Billion in the year 2027 trailing a CAGR of 8.4% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR while Rest of European market (as defined in the study) will reach US$1.1 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 376-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories

  • Abcam plc

  • Agilent Technologies

  • Becton, Dickinson and Company

  • Bio SB

  • Bio-Genex Laboratories

  • Cell Signaling Technology Inc.

  • F. Hoffmann-La Roche Ltd

  • Leica Biosystems Nussloch GmbH

  • Merck KGaA

  • QIAGEN N.V.

  • Sakura Finetek Japan Co. Ltd.

  • Thermo Fisher Scientific Inc.




Read the full report: https://www.reportlinker.com/p05799811/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Tissue Diagnostics Market: Prelude
Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
Breast Cancer Leads the Application Market for Tissue Diagnostics
Hospitals Represent the Leading End-Use Segment
Developed Regions Lead, Developing Economies to Spearhead Growth
Impact of COVID-19 on Healthcare & Pharmaceutical Industries
Competition
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Cancer Incidence Worldwide Spurs Demand for Tissue
Diagnostics
Global Cancer Incidence: Number of New Cancer Cases in Million
for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by
Cancer Site for 2018
Number of New Cancer Cases and Deaths (in Million) by Region
for 2018
Global Number of New Cancer Cases (in Million) in Men by Cancer
Site: 2018
Global Number of New Cancer Deaths (in Million) in Men by
Cancer Site: 2018
Global Number of New Cancer Cases (in Million) in Women by
Cancer Site: 2018
Global Number of New Cancer Deaths (in Million) in Women by
Cancer Site: 2018
Aging Population and Changing Lifestyles Drive Cancer
Incidence, Fueling Prospects for Tissue Diagnostics Market
Global Aging Population: Population of 65+ Individuals
(in Thousands) by Region for 2019 and 2030
Global Population of 65+ Individuals as % of Total Population
by Region for 2019 and 2030
Elderly Population (65+ Years) as a % of Total Population by
Developed, Less Developed and Least Developed Regions: 2019 &
2030
Global Cancer Deaths by Age Group (in %) for 2019
Increasing Healthcare Spending Levels Augur Well for the Market
Global Healthcare Market Size in $ Billion for the Years 2018-2022
Healthcare Expenditure as a % of GDP by Region for 2019
Per Capita Healthcare Spending (in $) in Select Countries for
the Year 2019
Growing Significance of Personalized Medicine: An Opportunity
for Tissue Diagnostics Market
Global Personalized Medicine Market: Revenues in US$ Million
for the Years 2019 and 2024
Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting
Therapy Decisions in NSCLCs
Sustained Advancements in Tissue Diagnostics Space Fuel Market
Prospects
Market Poised to Benefit from Digitalization of Tissue
Diagnostic Techniques & Automated Tissue Diagnostic Systems

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Tissue Diagnostics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 2: World Historic Review for Tissue Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 3: World 15-Year Perspective for Tissue Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for
Immunohistochemistry by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2020 through 2027

Table 11: World Historic Review for Immunohistochemistry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 12: World 15-Year Perspective for Immunohistochemistry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for in Situ
Hybridization by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2020 through 2027

Table 14: World Historic Review for in Situ Hybridization by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 15: World 15-Year Perspective for in Situ Hybridization
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Special Staining
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 17: World Historic Review for Special Staining by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 18: World 15-Year Perspective for Special Staining by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Digital Pathology &
Workflow by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2020 through 2027

Table 20: World Historic Review for Digital Pathology &
Workflow by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 21: World 15-Year Perspective for Digital Pathology &
Workflow by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Pharma Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 26: World Historic Review for Pharma Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 27: World 15-Year Perspective for Pharma Companies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Research
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2020 through 2027

Table 29: World Historic Review for Research Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 30: World 15-Year Perspective for Research Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 32: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Table 34: USA Current & Future Analysis for Tissue Diagnostics
by Product - Consumables and Instruments - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 35: USA Historic Review for Tissue Diagnostics by Product -
Consumables and Instruments Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 36: USA 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Tissue Diagnostics
by Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow - Independent
Analysis of Annual Sales in US$ Billion for the Years 2020
through 2027

Table 38: USA Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 39: USA 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 40: USA Current & Future Analysis for Tissue Diagnostics
by End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses - Independent Analysis of Annual Sales in
US$ Billion for the Years 2020 through 2027

Table 41: USA Historic Review for Tissue Diagnostics by End-Use -
Hospitals, Pharma Companies, Research Laboratories and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2019

Table 42: USA 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 44: Canada Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 45: Canada 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 47: Canada Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 48: Canada 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 49: Canada Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 50: Canada Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 51: Canada 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 53: Japan Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 54: Japan 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 56: Japan Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 57: Japan 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 58: Japan Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 59: Japan Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 60: Japan 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

CHINA
Table 61: China Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 62: China Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 63: China 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 65: China Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 66: China 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 67: China Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 68: China Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 69: China 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

EUROPE
Table 70: Europe Current & Future Analysis for Tissue
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2020 through 2027

Table 71: Europe Historic Review for Tissue Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 72: Europe 15-Year Perspective for Tissue Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 74: Europe Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 75: Europe 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 77: Europe Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 78: Europe 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 79: Europe Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 80: Europe Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 81: Europe 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

FRANCE
Table 82: France Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 83: France Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 84: France 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 86: France Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 87: France 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 88: France Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 89: France Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 90: France 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

GERMANY
Table 91: Germany Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 92: Germany Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 93: Germany 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 95: Germany Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 96: Germany 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 97: Germany Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 98: Germany Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 99: Germany 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

ITALY
Table 100: Italy Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 101: Italy Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 102: Italy 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 104: Italy Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 105: Italy 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 106: Italy Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 107: Italy Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 108: Italy 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 109: UK Current & Future Analysis for Tissue Diagnostics
by Product - Consumables and Instruments - Independent Analysis
of Annual Sales in US$ Billion for the Years 2020 through 2027

Table 110: UK Historic Review for Tissue Diagnostics by Product -
Consumables and Instruments Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2019

Table 111: UK 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Tissue Diagnostics
by Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow - Independent
Analysis of Annual Sales in US$ Billion for the Years 2020
through 2027

Table 113: UK Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 114: UK 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 115: UK Current & Future Analysis for Tissue Diagnostics
by End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses - Independent Analysis of Annual Sales in
US$ Billion for the Years 2020 through 2027

Table 116: UK Historic Review for Tissue Diagnostics by End-Use -
Hospitals, Pharma Companies, Research Laboratories and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2012 through 2019

Table 117: UK 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

SPAIN
Table 118: Spain Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 119: Spain Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2019

Table 120: Spain 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2020 & 2027

Table 121: Spain Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Billion
for the Years 2020 through 2027

Table 122: Spain Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 123: Spain 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2020 &
2027

Table 124: Spain Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 125: Spain Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 126: Spain 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

RUSSIA

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05799811/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001